Eisenstein, Neil M.; Eisenstein, Neil M.; Lawless, Bernard M.; Jamshidi, Parastoo; Segarra, Miren A.; Addison, Owen; Shepherd, Duncan E.T.; Attallah, Moataz M.; Grover, Liam M.; Cox, Sophie C.
Introduction 1
Additive manufacture (AM) is the process of creating a three-dimensional object 2 through layer-by-layer deposition of material. Commonly used AM techniques to melt 3 powdered metal material to create near net shape parts are selective laser melting 4 (SLM) and electron beam melting (EBM). Both of these approaches allow a greater 5 design flexibility than traditional manufacturing methods to produce metallic parts (1) ; 6 however, this advantage is not currently exploited to its full potential in medical 7 applications. The possibility of new implant designs produced via AM routinely 8 investigate osseointegration (2). However, increased functionality of implants can 9 also be created through incorporation and controlled local release of therapeutics 10
(3), or matching the mechanical properties of implants to the surrounding bone and 11 tissue, for example through graded structures (4). This improvement in implant 12 design has been possible due to the advances in additive manufacturing, where 13 conventional subtractive methods are not capable of achieving such complex 14
features. 15
Infection control of implants is a major concern in medicine, due to the increase in 2013, the prevalence of revision surgery due to prosthetic joint infection, within three 20 months of primary hip arthroplasty, increased 2.3-fold (5). Further, over 1000 21 procedures are performed due to prosthetic joint infection annually in this NJR region 22 (5). Incorporating a therapeutic agent into a temporary cement spacer is a common 23 solution to treat infection as it allows targeted local drug delivery with a controlled 24 release. When revision surgery is required due to infection of a primary hip 25 replacement, 2-stage hip revision is chosen to treat most cases (6, 7). However, a 1 cement hip spacer can result in poor patient quality of life during its implantation, due 2 to its limited strength resulting in restricted mobility (8). Thus, an implant that can 3 withstand normal loading conditions whilst eluting a desired therapeutic would be 4 advantageous. This may be realised by using AM technologies to create an internal 5 porous lattice structure to an implant that creates a void volume. A secondary 6 material loaded with an antibiotic could be incorporated into this void volume, such 7 as an antibiotic-loaded cement (9), and therapeutics released into the infected 8 surrounding tissue. It is important to consider the mechanical effect on an implant 9 when incorporating a lattice into a design, and ensure that fatigue and strength 10 criteria associated with the implant are still met. 11
To demonstrate the potential of AM in medical implants, optimisation of an alternate 12 2-stage hip revision spacer with internal lattice structuring was investigated in this 13 study, with an example design shown in Figure 1 . Titanium alloy (Ti-6Al-4V) was 14 chosen as the implant material due to its biocompatibility and suitability for 15 orthopaedic applications (10). SLM was chosen to manufacture lattices due to the 16 technologies capability to produce small strut diameters of 0.2 mm. It is critical for a 17 correctly designed implant to withstand deformation, due to induced stress from the 18 applied physiological loads, and also have a satisfactory fatigue strength. The aim of 19 this study was to develop and additively manufacture a lattice structure that could be 20 used in the design of a therapeutically loaded orthopaedic hip implant as an 21 alternative to a partial-load bearing traditional cement spacer. Ultimately this 22 approach has the potential to improve patient mobility and as such quality of life, as 23 well as decrease the need for secondary stage surgery associated with hip revision 24 due to infection. 25 for compression lattices, observing the relationship in equation 1 (11). The 10 association between average pore size (d a ) and diameter of cylindrical specimen is 11 specified by equation 2 (11). Notably, the resolution of the M2 Cusing® SLM system 12 (Concept Laser, Germany) requires a minimum strut diameter of approximately 13 0.2 mm to achieve an acceptable part quality. Therefore, designs of lattices were 14 kept within these parameters. 15 inappropriateness for design of AM medical implants. Resampling was set at 0.1 mm 20 as standard, but was adjusted to 0.2 mm when the number of elements of a 21 compression lattice exceeded 1 million. Using the Simpleware FE module 22 (Synopsys, Mountain View, USA), a coarse mesh was applied to the lattice 1 geometries and these were exported for finite element analysis (FEA). 2
To enable incorporation of the largest volume of therapeutic agent, the target volume 3 fraction (ratio of solid to void) of each cell type was decreased in increments of 10, 4 until the lowest possible volume fraction was identified whilst maintaining all design 5 parameters. The unit cell period (the number of cells that fill the image domain along 6 an axis) was varied in steps of 5. To maintain a cubic structure, the unit cell period 7 was identical in the X, Y, and Z directions. 8
As the volume fraction was decreased the strut diameter decreased also, 9 compensating for the reduction in volume by removing material from the unit cell 10 shape. Increasing the unit cell period also resulted in a decrease in strut diameter, as 11 more unit cells were fitted along each axis length of the image domain. Thus, after 12 determining the lowest volume fraction possible, the highest unit cell period was 13 designed for each compression lattice. This would present the smallest strut 14 diameter for each cell type that was within the limits of the SLM machine. FEA uses computational methods to simulate applied physical conditions to a 23 structure, and analyses the theoretical behaviour. In this study, Comsol 24 Multiphysics® v5.2 (Comsol AB, Stockholm, Sweden) was used to perform FEA. A 25 tetrahedral mesh was applied to each lattice geometry ( Figure 3 ). To simulate a 1 comparable force across all lattices, 2300 N was applied axially, and a fixed restraint 2 in all directions was applied to the bottom face. The 2300 N relates to the maximum 3 force applied during fatigue testing of orthopaedic hip implants, as described in ISO 4 7206-4, the international standard of implants for surgery -partial and total joint 5 prostheses (12). A stationary study was performed, using material properties for Ti-6 6Al-4V: Young's modulus of 113.8 GPa; Poisson's ratio of 0.342; and density of 7 4430 kg/m 3 (13). The maximum displacement and von Mises stress were used to 8 evaluate the performance of each design. 9
Manufacture of parts 10
Lattice cylinders were fabricated from Ti-6Al-4V gas atomised powder (TLS Technik, 11
Germany) sized 20-50 µm, with a M2 Cusing® SLM system (Concept Laser, 12 Germany). Recycled powder was sieved to ensure a powder size <60 µm. 13
Processing took place under an Argon atmosphere to limit oxygen pickup; the 14 atmosphere was controlled to <0.1% oxygen. An Nd:YAG laser was used, with a 15 maximum output power of 400 W, spot size of 60 µm, and wavelength of 1075 nm. 16
The same optimised process parameters, designed to reduce residual porosity, were 17 utilised from the authors' previous study (3). These parameters used an island 18 scanning strategy with a scanning speed of 1750 mm/s, hatch spacing of 75 µm, 150 19 W laser power, and 20 µm slice thickness. To improve stability during manufacture, 20 sacrificial support structures were built between the base substrate and each 21 individual lattice cylinder, which were removed after manufacture. 22
Micro-computed tomography 23
Lattice cylinders were scanned using a Skyscan1172 micro-computed tomography 1 (micro-CT) system (Bruker, Belgium) with 80 kV maximum X-ray energy, 8 W beam 2 power, 1750 ms exposure per projection, aluminium and copper filter, and 3.38 µm 3 pixel size. MicroCT was only employed on the Schwartz primitive (Pinched) 10% 4 lattices since reliable results on higher volume fraction lattices was unachievable due 5 to beam hardening and poor penetration of titanium. Reconstructed data were 6 visualised in 3D using CTVox software (version 3.0, Bruker). A porosity analysis was 7 performed using CTAn software (version 1.15.4.0, Bruker). Briefly, a region of 8 interest was created within the strut material of each lattice, and this was interpolated 9 across slices of the strut, to create a volume of interest (VOI) of approximately 0.015 10 mm 3 . Global thresholding was applied to create a binary image, and a 3D analysis 11 used to determine the total porosity within the VOI. The mean of 3 values taken from 12 separate struts was calculated for each sample (n = 5). 13
Porosity determination using an Archimedes balance 14
Using an Archimedes balance, the mass of the lattice cylinders was taken in both air 15 and ethanol, and additionally the height and diameter of each sample was measured 16 using a Vernier calliper. The density of the lattice material was calculated from 17 equation 3, where A is the mass of sample in air, B is the mass of sample in ethanol, 18 ρ O is the density of ethanol (0.79 g/cm 3 ), and ρ L is the density of air (0.0012 g/cm 3 ). 19
The apparent solid density (ρ C ) of the cylinder was calculated from equation 4, where 20 the volume of the cylinder (V) was calculated from its height and diameter and ρ T is 21 the theoretical density of Ti-6Al-4V (4.43 g/cm 3 ). The strut and pore dimensions could not be measured with Vernier callipers due to 3 their geometry within the lattice. Therefore, to validate the manufactured part versus 4 the stereolithography file (STL) sent for printing, images were taken of the 5 specimens and the minimum strut and average pore diameters were measured using 6
ImageJ (National Institutes of Health, Bethesda, MD, USA) ( Figure 4 ). The 7 photographic images allowed external features to be measured. Three repeat 8 measurements were taken, and the mean calculated for external minimum strut and 9 average pore diameters of manufactured lattices, with n = 5 for each lattice unit cell 10 type. In addition, ImageJ was used to measure average internal strut and pore 11 diameters for specimens scanned by micro-CT. Five repeat measurements were 12 taken for strut and pore diameters and the mean calculated, with n = 5 for sample 13 number. 14
Mechanical testing 15
Quasi-static compression tests were undertaken on n = 5 specimens per unit cell 16 type using a Z030 universal mechanical tester (Zwick/Roell, USA). Testing was 17 performed according to ISO 13314 (11). Each lattice was compressed at an initial 18 strain rate of 10 -2 s -1 to failure (0.075 mm/s). Failure strain was set to 50% of the 19 specimen height. However, all specimens failed before the 50% maximum strain limit 20 or reached the maximum load cell limit of 25 kN. Force and displacement were 21 measured by the machine and from this, stress-strain curves were plotted for each 22 test, where stress and strain were calculated from equation 5 and equation 6, 1 respectively. Following ISO 13314, results for quasi-elastic gradient (equation 7), 2 plateau stress between 5-9% strain ( Figure 5 ), first maximum compressive strength 3 ( Figure 5 ), energy absorption to 10% strain (equation 8) and energy absorption 4 efficiency (equation 9) were reported (11). If specimens did not fail before the 5 maximum load of 25 kN, the plateau stress could not be calculated. The plateau end 6 strain could not be calculated for any of the specimens. 7 F is the compressive force and A is the initial cross-sectional surface area 9 perpendicular to the loading force, in accordance with ISO 13314. Δl is the overall 10 compressive displacement, and l o is the initial gauge length. e 0 is the upper limit of 11 compressive strain (%) and σ 0 is the compressive stress at the upper limit of 12 compressive strain (N/mm 2 ), and e cr is the initial yield point corresponding to the start 13 of the plateau regime. 14 Fatigue testing was performed to emulate the testing standard ISO 7206-4 (12), 15 which determines the endurance properties of stemmed femoral components, on an 16
ElectroForce 3300 (Bose Corporation, ElectroForce Systems Group, Minnesota, 17 USA). A sinusoidally varying compressive force between 300 and 2300 N was 1 applied at 5 Hz until failure or run-out of 5 million cycles (12). The displacement of 2 lattices was recorded at 300 cycles (f), and as specified in ISO 7206-4 the test was 3 programmed to end if the specimen displaced greater than either 5 mm or 1.25 × f, 4 whichever was the greater value. Specimen sample size for fatigue testing was n = 5 3. 6
All mechanical testing was performed at room temperature. 
24

Fraction of volume and material 25
The volume fraction and material density for specimens with the largest volume 26 available for incorporation of a therapeutic agent were evaluated. Of the 27 manufactured specimens, the Schwartz primitive (Pinched) lattices at 10% volume 28 fraction, with unit cell period of 10 in the X, Y and Z axes, contained the highest 29 designed porosity. The level of defects within the manufactured specimens (i.e. 1 porosity within the lattice struts) calculated by microCT was 99.0 ± 0.7%. The density 2 of the lattice material was analysed using Archimedes balance measurements, as 3 4.24 ± 0.11 g/cm 3 , comparable to the theoretical density of Ti-6Al-4V (4.43 g/cm 3 ). 4
The volume fraction of the cylinder (designed to be 10%), was calculated from the 5 Archimedes balance measurements, as 14.18 ± 0.68%. For the Schwartz primitive 6 (Pinched) 10% lattices scanned by microCT and evaluated by ImageJ, no deviation 7 was found (variation of 3%) between the designed and manufactured internal strut The Schwartz primitive (Pinched) unit cell with 10% volume fraction and a cubic unit 6 cell function of 10 was chosen for fatigue testing, due to being the weakest 7 mechanical structure of the 4 manufactured lattices (Table 1 ) and containing the 8 greatest volume void space to incorporate a therapeutic agent. As the weakest 9 mechanical structure but with the largest volume available for therapeutic 10 incorporation, if the Schwartz primitive (Pinched) lattice with 10% volume fraction 11 passed fatigue testing then the stronger lattice types should withstand with fatigue 12 loading also in theory. Three samples completed 5 million cycles without failure 13 ( Supplementary Figure 1) . The samples displaced 0.381 ± 0.115 mm after 300 14 cycles (f), and after 5 million cycles this had increased to 0.393 ± 0.113 mm, thus all 1 samples passed the fatigue criteria (< 1.25 × f) set in ISO 7206-4. 2 3 Discussion 4
This paper describes a potential use of lattice design in orthopaedic implants, with 5 the 2-stage hip replacement spacer identified as a possible selection for redesign 6 due to its current limited life span and the inability for full patient load bearing. The 7 results of this study showed that the fatigue life of a Schwartz primitive (Pinched) unit 8 cell type, with 10% volume fraction and cubic cell function of 10, manufactured in Ti-9 6Al-4V by SLM, was suitable for use in the design of an orthopaedic hip implant. Use 10 of such a lattice design would allow for the incorporation of a therapeutic agent, such 11 as a resorbable antibiotic-loaded cement, to allow the targeted release of a drug. 12
This could reduce the overall amount of antibiotics required, as the targeted delivery 13 would allow release of the antibiotics locally rather than if administered by alternative 14 methods. Whilst the Schwartz primitive (Pinched) 10% lattice design reduces the 15 mechanical strength of the implant, this study demonstrates that the structure was 16 capable of meeting the axial load requirements of an orthopaedic hip implant, as 17 described by ISO 7206-4. A major advantage of this design would be the increased 18 mobility of a patient during a 2-stage hip revision. There is even the potential to use 19 the implant as a permanent prosthesis, which is especially beneficial in cases where 20 further surgery is undesirable, for example in elderly patients (14) or high risk 21 surgical cases (15). Although this study assessed the capability of designed lattice 22 structures to meet the axial load conditions of an orthopaedic hip implant, further 23 work would study the associated torsion and bending forces. 24 1 common minimum volume fraction of 30%. The Double Schoen gyroid, evaluated by 2 FEA, was the weakest lattice design (Figure 3; 1 .23 GPa von Mises stress), with a 3 predicted displacement of 0.7 mm; this was approximately ten times weaker than 4 other lattice designs. Another notably weak lattice was the Neovius' surface, with von 5
Mises stress of 1.05 GPa. The common design feature of these cell types is their 6 organic shape structure, compared to the more cubic design of other cells (Figure 2) . 7
As reported in other studies, stretch dominated structures are generally stiffer than 8 bending dominated structures, lending themselves as more suitable for weight 9 efficiency in structural applications (16). Since this study aimed to maximise the void 10 space available to determine the maximum volume of therapeutic agent that could 11 be incorporated, stretch dominated structures are an attractive solution to maintain 12 implant stiffness whilst removing material. This enables targeted drug delivery within 13 an orthopaedic implant and reduces the amount of antibiotics required to treat an 14 infection. Further, it provides a long-term implantable for when it is undesirable to 15 perform secondary surgery to remove a temporary cement spacer. The strongest 16 lattice types were the Schwartz primitive (Pinched) and Cylinder grid, with von Mises 17 stresses of 0.17 and 0.15 GPa, respectively (displacing 0.01 mm each). The FEA 18 results calculated in this study were used to inform the selection of lattice geometry 19 for AM and subsequently mechanical testing. Future work would involve validating 20 the FEA model to consider manufacturing defects and the influence of deviation from 21 the CAD model. 22
FEA was performed under identical conditions for all lattice types to provide a 23 comparison between designs. When evaluating lattice designs by FEA, stress 24 concentrations were noted at the edge of all specimens due to part cubic cells (cells 25 that were sectioned to fit within the cylindrical body). As noted in other studies, the 1 edge effect in FEA models of lattices makes it difficult to accurately model these 2 geometries (17). The displacement of Schwartz primitive (Pinched) manufactured 3 lattices (10% volume fraction) during fatigue testing was greater than predicted 4 during FEA (0.05 mm), due to specimens bedding in. Ultimately, although FEA 5 influenced the choice of which lattice geometries to manufacture, mechanical testing 6 of the lattices proved their validity as a choice for orthopaedic hip implants. The 7 compressive displacement of the Schwartz primitive (Pinched) lattices increased 8 during fatigue testing by 0.012 mm to 0.393 ± 0.113 mm, thus samples passed the 9 fatigue criteria (1.25 × f) set in ISO 7206-4. 10
The density of the printed titanium alloy, calculated within struts as 4.24 ± 0.11 11 g/cm 3 , is similar to the theoretical density of Ti-6Al-4V (4.43 g/cm 3 ). This result, 12 accompanied by the low level of porosity (1.0 ± 0.7%) calculated from microCT data, 13 confirms minimum defects within the solid material of the structure, even with small 14 strut diameters of 0.37 mm. 15
Notably, the accuracy of the manufactured specimens was close to the designed 16 parts as evidenced by dimensional measurements. Specifically, the average pore 17 size for Schwartz primitive, Schwartz primitive (Pinched) and Cylinder grid for the 18 designed and manufactured parts were similar; 6%; -2%; -3%; variation from design 19 respectively. Furthermore, the minimum strut diameters for the same cell types 20 measured from the manufactured parts exhibited 29%, -4% and 6% variation from 21 design respectively. Similarly, the designed strut and pore diameters of Schwartz 22 primitive (Pinched) 10% lattices were designed as 0.29 mm and 1.18 mm. The 23 external strut and pore diameters measured by photography and ImageJ varied by 24 28% and -3%, while the internal diameters (0.30 ± 0.03 mm and 1.22 ± 0.03 mm) 1 measured by microCT and ImageJ varied by 3% and 3%. Although the greatest 2 variability of strut diameter may appear high at 29% (Schwartz primitive (Pinched)), it 3 is worth noting that the standard deviation of measurements for the minimum struts 4 manufactured diameter deviated a maximum of 0.17 mm from the designed 5 geometry, and the average pore size a maximum of 0.11 mm. These values are 6 beyond the resolution of the SLM machine used (0.2 mm), and therefore it can be 7 assumed that the predominant cause of measurement variation is most likely due to 8 the triangulation process when creating an STL file. 9
Traditionally, AM implants are finished through polishing techniques, therefore, 10 further investigation to assess the challenges associated with finishing lattice 11 structures would be beneficial. Although the example in this paper has investigated 12 the potential of lattices in the design of orthopaedic hip spacers, another use of 13 lattices is to mechanically match an implant to surrounding tissue (18). Titanium 14 alloys are the traditional material of choice for manufacture of implants due to their 15 biocompatibility, corrosion resistance and mechanical properties (10, 19, 20) . 16
However, stress shielding is commonly cited as a barrier to titanium implants (19, 21, 17 22), since the material is significantly stiffer than that of the surrounding bone. The 18 elastic modulus of cortical and cancellous bone varies from 3 to 30 GPa and 0.02 to 19 0.3 GPa, respectively (23, 24), whereas the elastic modulus of Ti-6Al-4V is 20 significantly greater at 113 GPa (13). It is hypothesised that a lower Young's 21 modulus for the implant material results in more deformation of the implant and 22 therefore better bone ingrowth (25). A study by Schouman showed that by reducing 23 the overall stiffness of an implant through increased porosity, resulted in better bone 24 formation compared to a rigid design (21). By mechanically matching an implant to 25 surrounding bone, it is possible to prevent stress shielding and promote improved 1 osseointegration. The results of this study found that the quasi-elastic modulus of the 2 investigated lattices ranged from 0.92 ± 0.18 to 2.42 ± 0.09 MPa. These results are 3 within the range of those presented elsewhere: 2-6 GPa, with strut and pore 4 diameters of 400 µm and 650 µm, and relative density of 0.3 (26); and 0.5-1.5 GPa, 5 with 0.4 mm and 0.6 mm strut and pore diameter, and relative density 14% (27). 6
Notably, the results of this study are similar to the lower elastic modulus range of 7 cortical bone. Assuming a solid titanium structure would have an elastic modulus of 8 113 GPa, by varying the lattice geometry through an increase in volume fraction it is 9 predicted the modulus of the lattice structures could be designed to match the 10 variation in cortical bone. The manufactured specimens within this study failed at, or 11 around, a strain of 0.1 due to vertical struts within a layer fracturing. This strain range 12 is similar to that achieved in other studies (26). As vertical struts fractured at high 13 loads, the machine experienced rapid unloading (evident in Figure 5a ), and therefore 14 tests were automatically stopped at this point due to the machine safety mechanism. 15 These lattices, therefore, did not reach the plateau stage. The exception to this is the 16 Schwartz primitive (Pinched) 10% lattice, which failed before a strain of 0.1 but at a 17 much lower load (Figure 5c ), therefore plateau strength could be calculated for this 18 lattice type (Table 1) . 19
Although this study demonstrates the suitability of lattice geometries for use in load 20 bearing orthopaedic applications, their design was limited to cylindrical geometry 21 with constant cross-sectional area to comply with ISO 13314. The final geometry of 22 lattices is still to be determined. Future work would involve further testing to evaluate 23 the effect of cross sectional area over which the lattice was applied. A similar 24 approach could be adopted to this study, which iterates between FEA and 25 experimental analysis, to assess the design envelope in which this lattice could be 1
employed. 2
The use of AM is not currently being exploited to its full potential in medical devices. 3
This study assesses the potential of a lattice design as an alternative for a cement 4 hip spacer, notably this approach could add value to other orthopaedic cases. 5 Implementation could decrease complications such as stress shielding by matching 6 implant strength to patient-specific bone properties, or to allow targeted delivery of 7 drugs by incorporating a chamber within an implant whilst maintaining associated 8 strength and fatigue requirements. 9
Conclusions 10
The design of implants can be redefined to increase functionality due to advances in 11 additive manufacture, with orthopaedic implants no longer restricted to simply 12 mechanically replacing or supporting damaged joints and bones. Here, we explore 13 the potential to exploit the void volume of porous lattice structures as a reservoir for 14 a secondary material containing a therapeutic agent. There is also the potential to 15 design implants containing lattice structures to mechanically match surrounding bone 16 and reduce stress shielding. This study assessed the suitability of additively 17 manufactured titanium lattices as an alternative design for hip cement spacers, to 18 decrease associated morbidity and further surgery. The weakest lattice design 19 (Schwartz primitive (Pinched) 10%), with the greatest volume void, withstood 5 20 million cycles of loading between 300 and 2300 N. In summary, this study confirms 21 that AM methods can produce a lattice design for use in a titanium implant that could 22 allow targeted drug delivery of a loaded therapeutic, without compromising the 23 fatigue life of a load bearing orthopaedic hip implant. 
